# Shynianbio Inc.

Canonical: https://abierto.us/vendors/shynianbio-inc-xukam8hmlc71

- UEI: XUKAM8HMLC71
- CAGE: 9MSP0
- Location: San Francisco, CA
- Awards in window: 1 (3 transactions), $299,500 obligated, February 13, 2024 to February 19, 2025

## Awarding agencies

- National Institutes of Health: 1 awards, $299,500

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $299,500

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N91024C00004 (definitive contract): $299,500, NIH NCI. Phase I Therapeutic Award - Developing Split, Conditionally Active Peptidomimetics of IL-12 for the Treatment of Rare Pediatric Dipg. https://www.usaspending.gov/award/CONT_AWD_75N91024C00004_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/shynianbio-inc-xukam8hmlc71.